A Randomized Phase II Trial of Tamoxifen Versus Z-Endoxifen HCl in Postmenopausal Women With Metastatic Estrogen Receptor Positive, HER2 Negative Breast Cancer
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 03 Oct 2017
At a glance
- Drugs Endoxifen (Primary) ; Tamoxifen
- Indications Advanced breast cancer
- Focus Therapeutic Use
- 12 Jul 2017 Planned primary completion date changed from 1 May 2017 to 19 Feb 2018.
- 10 Jun 2017 Biomarkers information updated
- 18 Apr 2017 Status changed from recruiting to active, no longer recruiting.